Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.2276
H.R.2276: To require the Director of the United States Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.
About This Bill
- This bill was introduced in the 112th Congress
- This bill is primarily about commerce
- Introduced June 22, 2011
- Latest Major Action Aug. 25, 2011
Bill Sponsor
Bill Summary
Directs the Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (USPTO) to: (1) study ways to provide independent, confirming genetic diagnostic test activity where gene patents and exclusive licensing for primary genetic diagnostic tests exist; and (2) report the findings to Congress within nine months along with recommendations for establishing the availability of such independent...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
|
Referred to House Judiciary
|
|
Referred to House Energy and Commerce
|
|
Referred to the Subcommittee on Health.
|
|
Referred to the Subcommittee on Intellectual Property, Competition and the Internet.
|
|
June 22, 2011 |
Introduced in the House by Debbie Wasserman Schultz (D-Fla.) |